Multilateralism Failed Africa; Regionalism May Work Better – Africa CDC Deputy Head at European Health Forum Gastein 27/09/2021 Elaine Ruth Fletcher Multilateralism has “failed” to help Africa solve the COVID crisis and regional approaches to solving common problems could help the continent forge a “new public health order” said Africa Centers for Disease Control Deputy Director Ahmed Ogwell Ouma, speaking at the opening of the European Health Forum- Gastein. His statement at at the traditionally “Eurocentric” […] Continue reading -> As 70% of EU Adults are Vaccinated, Europe Proposes New Travel Restrictions 31/08/2021 Kerry Cullinan As the European Union (EU) announced on Tuesday that 70% of its adults had been fully vaccinated against COVID-19, it recommended reimposing restrictions on travellers from the US, Israel, Kosovo, Lebanon, Montenegro, and North Macedonia. On 8 June, the six were included on an EU Council list of “safe countries” identified for the relaxing of […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Travellers Vaccinated with Covishield ‘Should’ be Allowed into European Union – but Member States Have Final Say 30/06/2021 Kerry Cullinan Travellers who are fully vaccinated with vaccines authorised in the European Union (EU) “should” be allowed entry for non-essential travel – even if these vaccines were not “produced in facilities covered by the marketing authorisation in the EU”, a European Commission spokesperson for health, food safety and transport told Health Policy Watch on Wednesday. At […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> “Disrupting” The Status Quo – Multisectoral Actions For Health And Climate 05/10/2019 Elaine Ruth Fletcher & Grace Ren Bad Hofgastein, Austria – A call to action to make stronger individual and collective commitments for climate change and health marked the end of the European Health Forum (Gastein). The closing plenary session, titled “the global climate crisis: a public health emergency,” ended the varied program with discussions on two issues high on the political […] Continue reading -> Researchers & Policymakers Grapple With Medical Implications Of Cannabis 04/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – A stronger research agenda for cannabis is urgently required to guide European health policymakers through a bewildering maze of medical and recreational cannabis and cannabinoid products that are fast emerging on the European market, said researchers and policymakers at a panel session of the 2019 European Health Forum (Gastein), which concluded […] Continue reading -> Europe Charts Way Forward For Digital Health Solutions 03/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading -> Posts navigation Older postsNewer posts
As 70% of EU Adults are Vaccinated, Europe Proposes New Travel Restrictions 31/08/2021 Kerry Cullinan As the European Union (EU) announced on Tuesday that 70% of its adults had been fully vaccinated against COVID-19, it recommended reimposing restrictions on travellers from the US, Israel, Kosovo, Lebanon, Montenegro, and North Macedonia. On 8 June, the six were included on an EU Council list of “safe countries” identified for the relaxing of […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Travellers Vaccinated with Covishield ‘Should’ be Allowed into European Union – but Member States Have Final Say 30/06/2021 Kerry Cullinan Travellers who are fully vaccinated with vaccines authorised in the European Union (EU) “should” be allowed entry for non-essential travel – even if these vaccines were not “produced in facilities covered by the marketing authorisation in the EU”, a European Commission spokesperson for health, food safety and transport told Health Policy Watch on Wednesday. At […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> “Disrupting” The Status Quo – Multisectoral Actions For Health And Climate 05/10/2019 Elaine Ruth Fletcher & Grace Ren Bad Hofgastein, Austria – A call to action to make stronger individual and collective commitments for climate change and health marked the end of the European Health Forum (Gastein). The closing plenary session, titled “the global climate crisis: a public health emergency,” ended the varied program with discussions on two issues high on the political […] Continue reading -> Researchers & Policymakers Grapple With Medical Implications Of Cannabis 04/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – A stronger research agenda for cannabis is urgently required to guide European health policymakers through a bewildering maze of medical and recreational cannabis and cannabinoid products that are fast emerging on the European market, said researchers and policymakers at a panel session of the 2019 European Health Forum (Gastein), which concluded […] Continue reading -> Europe Charts Way Forward For Digital Health Solutions 03/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading -> Posts navigation Older postsNewer posts
15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Travellers Vaccinated with Covishield ‘Should’ be Allowed into European Union – but Member States Have Final Say 30/06/2021 Kerry Cullinan Travellers who are fully vaccinated with vaccines authorised in the European Union (EU) “should” be allowed entry for non-essential travel – even if these vaccines were not “produced in facilities covered by the marketing authorisation in the EU”, a European Commission spokesperson for health, food safety and transport told Health Policy Watch on Wednesday. At […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> “Disrupting” The Status Quo – Multisectoral Actions For Health And Climate 05/10/2019 Elaine Ruth Fletcher & Grace Ren Bad Hofgastein, Austria – A call to action to make stronger individual and collective commitments for climate change and health marked the end of the European Health Forum (Gastein). The closing plenary session, titled “the global climate crisis: a public health emergency,” ended the varied program with discussions on two issues high on the political […] Continue reading -> Researchers & Policymakers Grapple With Medical Implications Of Cannabis 04/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – A stronger research agenda for cannabis is urgently required to guide European health policymakers through a bewildering maze of medical and recreational cannabis and cannabinoid products that are fast emerging on the European market, said researchers and policymakers at a panel session of the 2019 European Health Forum (Gastein), which concluded […] Continue reading -> Europe Charts Way Forward For Digital Health Solutions 03/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading -> Posts navigation Older postsNewer posts
Travellers Vaccinated with Covishield ‘Should’ be Allowed into European Union – but Member States Have Final Say 30/06/2021 Kerry Cullinan Travellers who are fully vaccinated with vaccines authorised in the European Union (EU) “should” be allowed entry for non-essential travel – even if these vaccines were not “produced in facilities covered by the marketing authorisation in the EU”, a European Commission spokesperson for health, food safety and transport told Health Policy Watch on Wednesday. At […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> “Disrupting” The Status Quo – Multisectoral Actions For Health And Climate 05/10/2019 Elaine Ruth Fletcher & Grace Ren Bad Hofgastein, Austria – A call to action to make stronger individual and collective commitments for climate change and health marked the end of the European Health Forum (Gastein). The closing plenary session, titled “the global climate crisis: a public health emergency,” ended the varied program with discussions on two issues high on the political […] Continue reading -> Researchers & Policymakers Grapple With Medical Implications Of Cannabis 04/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – A stronger research agenda for cannabis is urgently required to guide European health policymakers through a bewildering maze of medical and recreational cannabis and cannabinoid products that are fast emerging on the European market, said researchers and policymakers at a panel session of the 2019 European Health Forum (Gastein), which concluded […] Continue reading -> Europe Charts Way Forward For Digital Health Solutions 03/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading -> Posts navigation Older postsNewer posts
United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> “Disrupting” The Status Quo – Multisectoral Actions For Health And Climate 05/10/2019 Elaine Ruth Fletcher & Grace Ren Bad Hofgastein, Austria – A call to action to make stronger individual and collective commitments for climate change and health marked the end of the European Health Forum (Gastein). The closing plenary session, titled “the global climate crisis: a public health emergency,” ended the varied program with discussions on two issues high on the political […] Continue reading -> Researchers & Policymakers Grapple With Medical Implications Of Cannabis 04/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – A stronger research agenda for cannabis is urgently required to guide European health policymakers through a bewildering maze of medical and recreational cannabis and cannabinoid products that are fast emerging on the European market, said researchers and policymakers at a panel session of the 2019 European Health Forum (Gastein), which concluded […] Continue reading -> Europe Charts Way Forward For Digital Health Solutions 03/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading -> Posts navigation Older postsNewer posts
EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> “Disrupting” The Status Quo – Multisectoral Actions For Health And Climate 05/10/2019 Elaine Ruth Fletcher & Grace Ren Bad Hofgastein, Austria – A call to action to make stronger individual and collective commitments for climate change and health marked the end of the European Health Forum (Gastein). The closing plenary session, titled “the global climate crisis: a public health emergency,” ended the varied program with discussions on two issues high on the political […] Continue reading -> Researchers & Policymakers Grapple With Medical Implications Of Cannabis 04/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – A stronger research agenda for cannabis is urgently required to guide European health policymakers through a bewildering maze of medical and recreational cannabis and cannabinoid products that are fast emerging on the European market, said researchers and policymakers at a panel session of the 2019 European Health Forum (Gastein), which concluded […] Continue reading -> Europe Charts Way Forward For Digital Health Solutions 03/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading -> Posts navigation Older postsNewer posts
European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> “Disrupting” The Status Quo – Multisectoral Actions For Health And Climate 05/10/2019 Elaine Ruth Fletcher & Grace Ren Bad Hofgastein, Austria – A call to action to make stronger individual and collective commitments for climate change and health marked the end of the European Health Forum (Gastein). The closing plenary session, titled “the global climate crisis: a public health emergency,” ended the varied program with discussions on two issues high on the political […] Continue reading -> Researchers & Policymakers Grapple With Medical Implications Of Cannabis 04/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – A stronger research agenda for cannabis is urgently required to guide European health policymakers through a bewildering maze of medical and recreational cannabis and cannabinoid products that are fast emerging on the European market, said researchers and policymakers at a panel session of the 2019 European Health Forum (Gastein), which concluded […] Continue reading -> Europe Charts Way Forward For Digital Health Solutions 03/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading -> Posts navigation Older postsNewer posts
“Disrupting” The Status Quo – Multisectoral Actions For Health And Climate 05/10/2019 Elaine Ruth Fletcher & Grace Ren Bad Hofgastein, Austria – A call to action to make stronger individual and collective commitments for climate change and health marked the end of the European Health Forum (Gastein). The closing plenary session, titled “the global climate crisis: a public health emergency,” ended the varied program with discussions on two issues high on the political […] Continue reading -> Researchers & Policymakers Grapple With Medical Implications Of Cannabis 04/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – A stronger research agenda for cannabis is urgently required to guide European health policymakers through a bewildering maze of medical and recreational cannabis and cannabinoid products that are fast emerging on the European market, said researchers and policymakers at a panel session of the 2019 European Health Forum (Gastein), which concluded […] Continue reading -> Europe Charts Way Forward For Digital Health Solutions 03/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading -> Posts navigation Older postsNewer posts
Researchers & Policymakers Grapple With Medical Implications Of Cannabis 04/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – A stronger research agenda for cannabis is urgently required to guide European health policymakers through a bewildering maze of medical and recreational cannabis and cannabinoid products that are fast emerging on the European market, said researchers and policymakers at a panel session of the 2019 European Health Forum (Gastein), which concluded […] Continue reading -> Europe Charts Way Forward For Digital Health Solutions 03/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading -> Posts navigation Older postsNewer posts
Europe Charts Way Forward For Digital Health Solutions 03/10/2019 Elaine Ruth Fletcher Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading -> Posts navigation Older postsNewer posts